Recently clinical application and research has begun to focus on the application of BFR for the geriatric sarcopenic patient, pediatrics and non-orthopedic diagnosis such as diabetes and Parkinson's disease. Additionally, angiogenic benefits and bone sparing mechanisms have increased research interest in the use of BFR to address vascular diseases and improve bone quality after surgery.

Thank you to our sponsor:

Presenter:

Johnny Owens, PT, MPT, is CEO and Director of Clinical Education for Owens Recovery Science, a corporation recognized in the INC 500. He manages a research portfolio of over 40 clinical trials being conducted worldwide primarily studying the effects of Blood Flow Restriction Rehabilitation in clinical populations. He serves as a medical consultant for teams in the NFL, NBA, MLB, NHL and collegiate sports.

He is involved in numerous clinical trials involving regenerative medicine, sports medicine, blood flow restriction and high-energy trauma. Owens has been published extensively in the peer-reviewed literature, regularly speaks at the national and international level and his work has been featured on 60 Minutes, Time Magazine, NPR, Discovery Channel and ESPN.